Global Biosimilar Companies You Must Know About
12 March 2026 Category: Clinical TrialBiologic medicines changed modern healthcare. They treat complex diseases like cancer, autoimmune disorders, and diabetes.
Biologic medicines changed modern healthcare. They treat complex diseases like cancer, autoimmune disorders, and diabetes.
Pharma R&D waste is often mistaken for scientific failure. In reality, a large portion of it is strategic and preventable.
The generic injectable market is not glamorous. It is not trendy either. But it prints money.
The biosimilar market is getting bigger, faster, and honestly a little chaotic. Patent cliffs are coming one after another, biologics are losing exclusivity across the world, and every pharma company wants a piece of the action.
Bottom line is, 2026 will is going to be one of the most important years for healthcare sector. So let’s dive in, and get a better look at what next year have up it’s sleeves.